[Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease].
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D004359:Drug Therapy, Combination; D005934:Glucagon / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy* / Q000378:metabolism; D008926:Plicamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D005934:Glucagon; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D008926:Plicamycin
Les effets cliniques et métaboliques de la mithramycine et du glucagon sur le traitement de la maladie de Paget.